Healthcare -
Biotechnology - NASDAQ - US
$ 26.33
-8.8 %
$ 2.96 B
Market Cap
-26.07
P/E
VKTX - OTHER CURRENT LIABILITIES
Other Current Liabilities VKTX - Viking Therapeutics, Inc.
11.3 M
LAST VALUE
24.62%
2 YEAR CAGR
25.77%
5 YEAR CAGR
110.85%
10 YEAR CAGR